EW vs K · P/E 47, rev $1.39B vs P/E 23, $29.03B cap
Edwards Lifesciences Corp (EW) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Kellanova (K) is a packaged foods company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
K does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the EW and K stock pages for the full models.
Not investment advice.